`
Monday, 26 June 2017

Korea News

  • Asian endoscopy market clocked $264.7 mn in 2012

    Korea |  News | By BioSpectrum Bureau | 0 Comment | 10 Dec, 2013

    Singapore: Endoscopy devices market in Australia, South Korea, and Southeast Asia, earned revenues of USD264.7 million in 2012 and estimates this to reach USD408.3 million in 2017, accordin...Read more

  • Korea's LSK Global strengthens ties with Medidata

    Korea |  News | By BioSpectrum Bureau | 0 Comment | 14 Jun, 2016

    Singapore: Korea's leading CRO, LSK Global has expanded its use of Medidata Clinical cloud platform, thus strengthening its global R&D capabilities. The Seoul based organization was est...Read more

  • Linagliptin efficacy further established in specific patient populations

    Korea |  News | By Nandita Singh | 0 Comment | 12 Nov, 2013

    Seoul: Boehringer Ingelheim and Eli Lilly & Company have announced new data that reinforces the efficacy and tolerability of linagliptin in patients with Type 2 Diabetes (T2D) and liver...Read more

  • Boehringer Ingelheim, Hanmi to co-develop lung cancer drug

    Korea |  News | By BioSpectrum Bureau | 0 Comment | 30 Jul, 2015

    Singapore: Boehringer Ingelheim and Korea's Hanmi Pharmaceutical have collaborated for the development and global commercialisation rights, except South Korea, China and Hong Kong, of HM617...Read more

  • South Korea, EU join hands for bio-nano research

    Korea |  News | By BioSpectrum Bureau | 0 Comment | 17 Jun, 2015

    Singapore: In a bid to boost its biotech and nanotechnology sectors, South Korea has inked a $80 million pact with the European Union (EU) to leverage EU's capabilities in science technolog...Read more

  • CrystalGenomics partners with Dong-A for Acelex commercialization

    Korea |  News | By BioSpectrum Bureau | 0 Comment | 14 Aug, 2015

    Singapore: Korea based CrystalGenomics has signed a sales and marketing agreement with Dong-A ST for the commercialization of Acelex (polmacoxib) in Korea. Acelex is a tissue-selective, on...Read more

  • Samsung progresses on RA biosilimar drug ph 3 trial

    Korea |  News | By BioSpectrum Bureau | 0 Comment | 21 Jul, 2015

    Singapore: Korea pharma giant, Samsung Bioepis, has successfully completed Phase 3 clinical study of SB5, an investigational biosimilar of Humira (adalimumab)for treating rheumatoid arthrit...Read more

  • Vigilant Biosciences enters Korea's oral cancer market

    Korea |  News | By BioSpectrum Bureau | 0 Comment | 11 Mar, 2015

    Singapore: Vigilant Biosciences, developer of early detection and intervention technology for oral cancer, has entered into a five-year exclusive sales and marketing distribution agreement ...Read more

  • Dong-A Pharma diversifies portfolio to include biosimilars

    Korea |  Analysis | By Amrita Tejasvi | 0 Comment | 04 Jun, 2013

    Clocking revenues of $995.40 million, Dong-A pharmaceutical is acknowledged as a leading name in Korea's pharmaceutical industry. Over the years, the company has built alliances with inte...Read more

  • Samsung to construct a new drug manufacturing plant

    Korea |  News | By BioSpectrum Bureau | 0 Comment | 01 Dec, 2015

    Singapore: Samsung BioLogics, biologic drug-manufacturing arm of Samsung Group said that it would invest 850 billion Korean won ($740 million) to construct a new biologic drug manufacturing...Read more

  • BioElectronics enters Korean pain relief market

    Korea |  News | By BioSpectrum Bureau | 0 Comment | 05 Apr, 2013

    Singapore: BioElectronics, the maker of unique pain relief, inexpensive, patented, consumer medical devices, begun product distribution of its ActiPatch Musculoskeletal Pain Relief, Allay M...Read more

  • Asia an emerging hotspot in medical tourism

    Korea |  Analysis | By Aishwarya Venkatesh | 0 Comment | 09 Mar, 2015

    Singapore: BioSpectrum feels the pulse of Asia's top destinations and major players in medical tourism.  Medical tourism industry is growing worldwide. Frost and Sullivan predicts that t...Read more

  • Korean Shin Poong and French LFB set up JV

    Korea |  News | By BioSpectrum Bureau | 0 Comment | 17 Jan, 2013

    Singapore: South Korean drugmaker, Shin Poong Pharmaceutical, and France's Laboratoire francais du Fractionnement et des Biotechnologies (LFB) signed a term sheet for setting up a joint ven...Read more

  • Green Cross to expand biologics market in Russia

    Korea |  News | By BioSpectrum Bureau | 0 Comment | 03 Apr, 2015

    Singapore: Korea based biopharmaceutical company, Green Cross, has partnered with Nanolek, a Russian pharmaceutical company, for the commercialisation of Green Cross' biologics in the Russi...Read more

  • China surpasses Korea in sci-tech competitiveness

    Korea |  News | By BioSpectrum Bureau | 0 Comment | 12 Feb, 2013

    Singapore: A report published on February 11 by the Hyundai Economic Research Institute titled, 'Comparison of Korea-China Science Technology Competitiveness', has highlighted that China's ...Read more

  • Samsung eyes Nasdaq listing to raise cash

    Korea |  News | By BioSpectrum Bureau | 0 Comment | 30 Jun, 2015

    Singapore: Korean drugmaker Samsung Bioepis has declared plans to list on Nasdaq with eyes on raising cash to manufacture and market cheaper copies of blockbuster biologics. Mr Yang Chul-b...Read more

  • Korean companies lag behind in new drug research: Report

    Korea |  News | By BioSpectrum Bureau | 0 Comment | 04 Aug, 2015

    Singapore: Korean pharmaceutical companies were found to be lagging behind in new product development, according to a new report released by B2Pharm's Green List Alert service, which publis...Read more

  • Korea's ImmunoMet raises $5.2 mn

    Korea |  News | By BioSpectrum Bureau | 0 Comment | 14 Mar, 2016

    Singapore: Korea based ImmunoMet Therapeutics, a biotechnology company developing innovative drugs for the treatment of cancer, has raised $5.2 million in a Series A financing led by Mirae ...Read more

Survey Box

Will Asia- Pacific healthcare IT market hit the double digit growth in the next five years?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls